FDA Approves First Nasal Spray for Treatment of Anaphylaxis
Today, the U.S. Food and Drug Administration approved neffy (epinephrine nasal spray) for the emergency treatment of allergic reactions (Type I), including those that are life-threatening...
Nasal Spray and Inhalation Solution, Suspension, and Spray Drug ...
This document provides guidance for industry on the chemistry, manufacturing, and controls (CMC) documentation that should be submitted in new drug applications (NDAs) and …
FDA approves nasal spray as first needle-free treatment for …
The FDA has approved a nasal spray as the first needle-free treatment for potentially fatal allergic reactions. The spray is intended as an alternative to EpiPen and other autoinjectors.
FDA approves first nasal spray to treat anaphylaxis
Aug 9, 2024 · The Food and Drug Administration (FDA) has approved neffy epinephrine nasal spray from ARS Pharmaceuticals for the emergency treatment of anaphylaxis in people …
FDA Approves First Nasal Spray for Allergic Reactions - WebMD
Aug 9, 2024 · The FDA announced its approval of the nasal spray, called neffy, on Friday. It's for adults, and for children who weigh at least 66 pounds, who have what are known as type 1 …
Epinephrine Nasal Spray to Treat Anaphylaxis is Now Available
Aug 9, 2024 · Epinephrine auto-injectors received FDA approval in 1987 and have been the standard treatment for anaphylaxis ever since. The new nasal spray is a needle-free …
FDA Approves First Nasal Spray for Treatment of Anaphylaxis
SILVER SPRING, Md., Aug. 9, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved neffy (epinephrine nasal spray) for the emergency treatment of …
Nasal spray Neffy gets FDA approval to treat allergic reactions - USA TODAY
Aug 9, 2024 · The Food and Drug Administration approved a new nasal spray Friday as the first needle-free emergency treatment for potentially fatal allergic reactions.
5 Things to Know About neffy, the New Nasal Spray for Anaphylaxis
Oct 8, 2024 · The Food and Drug Administration (FDA) approved neffy in August 2024 for adults and children who weigh at least 66 pounds after giving the product a “Fast Track” designation, …
FLONASE nasal spray is a corticosteroid indicated for the management of the nasal symptoms of perennial nonallergic rhinitis in adult and pediatric patients aged 4 years and older. (1) For...